Iteos Therapeutics, Inc. (ITOS) Stock Leaping Forward in Aftermarket, Here’s the Reason

 Iteos Therapeutics, Inc. (ITOS), a clinical-stage biopharmaceutical company, has surged 6.94% in aftermarket trading session. Consequently, ITOS stock is trading at $49.79 at the time of the writing. The surge could be attributed to the announcement of ITOS addition to S&P SmallCap 600. On Friday, ITOS closed the day at $46.56 after declining 2.49% during […]

News IMC
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.